MONROE SURGICAL HOSPITAL — History
CCN 190245 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$26M
Latest Revenue (FY2022)
+12.9%
Revenue CAGR (3yr)
-11.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $20M | $25M | $26M | +4.8% | +12.9% |
| Operating Expenses | $25M | $27M | $29M | +6.0% | +7.2% |
| Operating Margin | -24.0% | -10.6% | -11.9% | -11.9% | +0.0% |
| Net Income | $-5M | $-3M | $-3M | -17.3% | +0.0% |
| Licensed Beds | 10 | 10 | 10 | +0.0% | +0.0% |
| Total Patient Days | 370 | 357 | 444 | +24.4% | +9.5% |
| Medicare Day % | 49% | 36% | 24% | -32.2% | -29.9% |
| Medicaid Day % | nan% | nan% | 2% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +27.4% ($20M → $26M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.9%
This Hospital
+7.6%
State Avg
Latest Margin
-11.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $29M | -5.8% |
| FY2024 (proj) | $31M | 0.3% |
| FY2025 (proj) | $34M | 6.3% |